Status | Study |
NOT_YET_RECRUITING |
Study Name: Natural History of Netherton Syndrome Condition: Date: 2023-05-24 |
RECRUITING |
Study Name: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome Condition: Netherton Syndrome Date: 2023-04-26 Interventions: Solution for infusion |
RECRUITING |
Study Name: Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome Condition: Netherton Syndrome Date: 2023-03-16 Interventions: QRX003Topical Lotion containing 4% active drug (serine protease inhibitor) |
Recruiting |
Study Name: The Efficacy and Safety of Secukinumab in Patients With Ichthyoses Condition: Ichthyosis Autosomal Recessive Congenital Ichthyosis Lamel Date: 2017-01-17 Interventions: Drug: Secukinumab Anti IL-17A |
Active, not recruiting |
Study Name: Clinical Trial Using Humira in Netherton Syndrome Condition: Netherton Syndrome Date: 2014-04-02 Interventions: Drug: Adalimumab |
Recruiting |
Study Name: Natural History and Biological Study of Netherton Syndrome Condition: Netherton Syndrome Healthy Date: 2014-03-05 Interventions: Other: Biopsy Other: Blood sample |
Recruiting |
Study Name: Gene Therapy for Netherton Syndrome Condition: Netherton Syndrome Date: 2012-03-01 Interventions: Genetic: One 20cm2/10cm2 autologous skin sheet graft Adults will receive a graft of approximately 20cm2. |
Completed |
Study Name: A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome Condition: Healthy Volunteers Atopic Dermatitis Date: 2011-08-19 Interventions: Drug: BPR277 ointment (controlled application) |
Recruiting |
Study Name: Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways Condition: Atopic Dermatitis Date: 2010-07-15 |
Completed |
Study Name: Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome Condition: Netherton Syndrome Date: 2005-09-13 Interventions: Drug: Pimecrolimus 1% Cream Open label single arm Ot |